Release Date: May 30, 2025
Expiration Date: May 30, 2026
Activity Overview
With recent additions to treatment options for neovascular age-related macular degeneration (nAMD) come new questions. How can newer anti-VEGF therapies affect the treatment burden for patients with nAMD? Which patients can attain longer treatment intervals, and what are the criteria to determine the optimal interval? In this program, expert faculty presents illustrative cases of patients with nAMD managed with recently approved therapies and discusses the outcomes – including reduced treatment burden – that they can achieve.
Target Audience
Retina Specialists
Learning Objectives
Upon successful completion of this activity, you should be better prepared to:
- Recognize appropriate applications of evidence-based therapies used in the management of nAMD based on patient presentation and treatment goals
- Summarize the impact of advanced anti-VEGF treatments in the management of nAMD
Nathan C. Steinle, MD
Retina Surgeon
California Retina Consultants
Retina Consultants of America
Santa Barbara, CA
Disclosures: Consultant: Allergan, Inc: Grant/Research Support; Allergan, Inc
Faculty, Staff, and Planners’ Disclosures
The staff of Physicians’ Education Resource, LLC, (PER®) have no relevant financial relationships with ineligible companies.
PER mitigated all conflict of interest for faculty, staff, and planners prior to the start of this activity by using a multistep process.
Off-Label Disclosure and Disclaimer
This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER or any company that provided commercial support for this activity.
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here